These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 619198)

  • 1. Head and neck cancer State of the Art converence. Section I. Immunology.
    Baram P
    Laryngoscope; 1978 Jan; 88(1 Pt 2 Suppl 8):10-1. PubMed ID: 619198
    [No Abstract]   [Full Text] [Related]  

  • 2. [Tumor biology, immunology, immunotherapy of head and neck carcinoma].
    Z Stomatol; 1986 Apr; 83(2):185-93. PubMed ID: 3463106
    [No Abstract]   [Full Text] [Related]  

  • 3. [Is there a role for immunology in the prevention of malignant tumors of the head and neck?].
    Beatrice F; Cortesina G; Succo G; Spiga G; Bessone F; Pecorari G; Sartoris A
    Acta Otorhinolaryngol Ital; 1990; 10 Suppl 27():55-8. PubMed ID: 2203225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Head and neck tumor immunology.
    Carneiro CR
    Rev Paul Med; 1993; 111(4):6-7. PubMed ID: 8108652
    [No Abstract]   [Full Text] [Related]  

  • 5. Recent advances in immunology with specific reference to otolaryngology.
    Naclerio R
    Otolaryngol Clin North Am; 1985 Nov; 18(4):821-32. PubMed ID: 3909062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in the immunology of head and neck cancer.
    Katz AE
    Otolaryngol Clin North Am; 1980; 13(3):431-6. PubMed ID: 6777739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. General immune competence in cancer patients--head and neck.
    Eilber FR
    Laryngoscope; 1978 Jan; 88(1 Pt 2 Suppl 8):28-30. PubMed ID: 619203
    [No Abstract]   [Full Text] [Related]  

  • 8. [Tumor markers of malignant head and neck neoplasms].
    di Nasso F
    Acta Otorhinolaryngol Ital; 1987; 7(3):239-82. PubMed ID: 3661168
    [No Abstract]   [Full Text] [Related]  

  • 9. A review of immunology and head and neck tumors.
    Church JM; Ryan RF
    Clin Plast Surg; 1976 Jul; 3(3):385-8. PubMed ID: 963948
    [No Abstract]   [Full Text] [Related]  

  • 10. Cellular immunity in patients with head-and-neck cancer.
    Skinner MD; Kashima HK; Braverman G; Kalinowski B
    Ear Nose Throat J; 1979 Feb; 58(2):98-100. PubMed ID: 436684
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunobiologic aspects of head and neck cancer. Clinical and laboratory correlates.
    Vlock DR
    Hematol Oncol Clin North Am; 1991 Aug; 5(4):797-820. PubMed ID: 1716250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal antibodies (Mabs) in head and neck cancer.
    Poliquin JF; Filion LG
    J Otolaryngol; 1986 Oct; 15(5):289-92. PubMed ID: 3534285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Head and neck oncology--1985. Reflections on changing times.
    Sessions RB; Starnes HF
    Otolaryngol Clin North Am; 1985 Aug; 18(3):433-44. PubMed ID: 2995898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alcohol consumption and cellular immunocompetence.
    Palmer DL
    Laryngoscope; 1978 Jan; 88(1 Pt 2 Suppl 8):13-7. PubMed ID: 619200
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunological methods in diagnosis and monitoring of head and neck cancer.
    Mitchell MS
    Laryngoscope; 1978 Jan; 88(1 Pt 2 Suppl 8):18-9. PubMed ID: 339021
    [No Abstract]   [Full Text] [Related]  

  • 16. [Recognition of malignant skin tumors of the head and neck].
    de Visscher JG; Blanken R; van der Lei B
    Ned Tijdschr Tandheelkd; 2002 Feb; 109(2):51-5. PubMed ID: 11933566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental head and neck oncology.
    Schantz SP
    Curr Opin Oncol; 1990 Jun; 2(3):546-51. PubMed ID: 1965489
    [No Abstract]   [Full Text] [Related]  

  • 18. Serum immunoglobulin A (IgA) levels in carcinoma of the head and neck.
    Katz AE; Yoo TJ; Harker LA
    Trans Sect Otolaryngol Am Acad Ophthalmol Otolaryngol; 1976; 82(2):131-7. PubMed ID: 820030
    [No Abstract]   [Full Text] [Related]  

  • 19. Deficient immunity in head and neck cancer due to excessive monocyte production of prostaglandins.
    Berlinger NT
    Laryngoscope; 1984 Nov; 94(11 Pt 1):1407-10. PubMed ID: 6593559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Head and neck tumour immunology: basic concepts and new clinical implications.
    Topping KP; Fletcher LM; Agada FO; Alhamarneh O; Stafford ND; Greenman J
    J Laryngol Otol; 2009 Jan; 123(1):9-18. PubMed ID: 18761764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.